Sign in
Taking people in AustriaPhase 2

Epiflux trial for adults with focal epilepsy

Tests Epiflux in adults with focal epilepsy, a seizure disorder.

Key facts

Who runs it
Medical University Of Vienna
Where
Vienna, AustriaSee the site
Registry title
Epiflux
Status
Recruiting
Phase
Phase 2
People taking part
60 people, planned
Started
15 Apr 2020
Expected to end
1 Jun 2029
Type of study
Interventional
Record updated
14 October 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with focal epilepsy. The record gives no other details.

Age
18 years or older
Sex
All sexes can join

Where in Austria

  • Medical University of ViennaVienna, AustriaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Epiflux trial for adults with focal epilepsyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
14 October 2024